CE-IVD Cancer Genomics
We are pleased to provide access to a CE-marked solution for clinical genomic analysis.
The full spectrum of the assay covers >6700 clinically significant genes with a read depth of 20x providing >99% coverage for coding and splice sites. This is broken down into panels of genes relevant to different cancers.
The genetic results are interpreted in the context of your cancer for maximum relevance and actionability.
50 Gene Cancer Panel
50 Gene Cancer Panel:
This panel includes genes associated with moderate to high risk of hereditary cancer and has established clinical management guidelines for disease-causing variants. It provides the optimal balance between detection of pathogenic cancer susceptibility variants whilst minimising reporting of variants with unknown clinical significance.